Wall Street Pulls Back on Novo Nordisk and Jefferies
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesStocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Carnival reports a sharp rise in adjusted earnings for 2025 and improves leverage metrics, even as fuel costs and sec...
Wells Fargo cuts Gartner's price target to $140 as macro volatility tied to geopolitical tensions and AI competition ...
Retirement planning isn’t only about investments. Health coverage decisions during the March window can affect your c...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
Two benchmarks gave two opposite results for Claude Fable 5. The mystery isn't a nerf—it's the routing layer. Learn h...
As AI-driven data center needs surge, Micron could defy typical cycles. This guide lays out why prediction: micron st...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
Energy markets move fast, but a 10-year horizon changes the game. This guide helps you identify what best energy stoc...
Powell's warning to Wall Street is shaping market expectations as AI optimism runs high. This article breaks down wha...
Oil markets face a persistent pricing regime, per Shell’s warning. This guide translates that view into practical inv...